Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

7 Wins for Pulsar!

February 11, 2011 Medical Communications, Sales and Marketing

Pulsar have done very well of late and managed to bag 1 silver Rx award and  6  New York Rx …
Feature
Thought Leadership

Shire thrives on specialist portfolio

February 11, 2011 Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse

Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …
News

Pierre Fabre loses chief executive

February 11, 2011 Sales and Marketing Olivier Bohuon, Pierre Fabre, Smith & Nephew, appointment, medical devices, sales and marketing

Olivier Bohuon is leaving French pharma company Pierre Fabre after serving just five months as its chief executive. He will …
Appointment
Eli Lilly chief executive John Lechleiter

Lilly chief issues warning on UK reforms

February 11, 2011 Research and Development, Sales and Marketing John Lechleiter, US health reforms, healthcare reform, lilly, patent box, value-based pricing

Lilly chief executive John Lechleiter has warned that two key UK initiatives could fall seriously short of encouraging investment in …
News

Innovation is being stifled – Lilly chief executive

February 10, 2011 Research and Development, Sales and Marketing Economist 2011 Pharma Summit, US health reforms, healthcare costs, healthcare reform, lilly

Supporting medical innovation should be a fundamental requirement of healthcare reforms, but current public policies are failing to do this, …
News
Blog footer

Digital Pharma: This is how pharma is using digital

February 10, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Android, Digital Pharma blog, Facebook, Twitter, disease awareness campaigns, ipad, iphone, social media

Pharma’s use of digital tools, from mobile apps to online campaigns to social media channels, is increasing all the time …
Feature

Amarin expands US operations

February 10, 2011 Sales and Marketing AMR101, Amarin, Paul Huff, high cholesterol

Dublin-based biopharmaceutical company Amarin is to increase its US presence by setting up sales and marketing headquarters in New Jersey. …
News
GSK's swine flu vaccine Pandemrix

WHO wants narcolepsy link with swine flu vaccine investigated

February 10, 2011 Research and Development, Sales and Marketing Finland Institute, GSK, GlaxoSmithKline, Pandemrix, narcolepsy, swine flu

The World Health Organisation has called for further investigation into GSK’s swine flu vaccine link to sleeping disorder narcolepsy, following …
News

Generics force Sanofi into standstill

February 9, 2011 Sales and Marketing 2010 pharma results, Jevtana, Multaq, Sanofi, Sanofi-Aventis, generics

An onslaught of generic competition combined with healthcare cuts in the US and Europe meant Sanofi-Aventis’ revenues were brought to …
News
Diabetes injection

Pharma-NHS diabetes project begins

February 9, 2011 Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working

A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …
News

Teva surges ahead

February 9, 2011 Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical

Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …
News

Roche eyes ovarian cancer expansion for Avastin

February 8, 2011 Sales and Marketing Cancer, Roche, avastin, bevacizumab, ovarian cancer

Roche has submitted an EU marketing authorisation for Avastin for the treatment of ovarian cancer and plans to file the …
News

Merck KGaA appoints Frederic Wohlwend

February 7, 2011 Sales and Marketing Frederic Wohlwend, Merck KGaA, appointment, sales and marketing

Frederic Wohlwend has been promoted to chief information officer at Merck KGaA with effect from 1 April. He succeeds Kai …
Appointment
Roche's Avastin (bevacizumab)

Survey shows doctors support FDA Avastin decision

February 7, 2011 Sales and Marketing FDA, Roche, Sermo, avastin, bevacizumab

A survey of US doctors suggests that a majority support the FDA’s decision to take away Avastin’s licence for use …
News

GSK profits slump amid ongoing Avandia woes

February 7, 2011 Sales and Marketing 2010 pharma results, Avandia, GSK, GlaxoSmithKline

GlaxoSmithKline’s ongoing woes with diabetes drug Avandia hit profits in 2010. Profits after tax plummeted 56% to £3 billion for …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026